Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant: Prevention of Cardiovascular and Respiratory Diseases

University of British Columbia

$275,531.00

Ethnic-Specific Variations in Adiponectin, Adiposity, & Risk for CVD

EF 2009-10

Résumé
Twenty-three percent of adult Canadians are obese (BMI¡Ý30). Increased visceral adipose tissue (VAT), a component of obesity, is an independent risk factor for cardiovascular disease (CVD) but the molecular mechanisms underlying VAT deposition and how it leads to CVD are not known. The Multicultural Community Health Assessment Trial (M-CHAT) is a research program (Dr S Lear, Co-applicant) to explore obesity and CVD risk in Aboriginal, Chinese, European, and South Asian adults. Recent findings indicate that ethnicity predicts body fat distribution, independent of socioeconomic status and lifestyle. The objective of this proposal is to test the HYPOTHESIS that GENETIC AND/OR EPIGENETIC VARIATIONS in ADIPONECTIN (ADIPOQ gene) and ADIPONECTIN RECEPTOR (ADIPOR1 gene) EXPRESSION CONTRIBUTE to ETHNIC-SPECFIC DIFFERENCES in VAT and CVD RISK. We have chosen to focus on adiponectin because of the potential role for adiponectin in CVD and the inverse association of circulating adiponectin with VAT. These SPECIFIC AIMS will be addressed : 1. To determine the contribution of variants in ADIPOQ (A-11426G, G-11388A, C-11377G, and T45G), and ADIPOR1 (C-8503T, G-7308A, G-7302A, and G-6871A), and ADIPOQ and ADIPOR1 promoter methylation status to differences in plasma adiponectin, VAT deposition and carotid atherosclerosis in the M-CHAT subjects at baseline. 2.To determine the relationship of ADIPOQ and ADIPOR1 promoter methylation status and mRNA expression to differences in plasma adiponectin, VAT deposition and carotid atherosclerosis in a follow-up of M-CHAT subjects (3-4 yrs post baseline). 3. To determine if ADIPOQ and ADIPOR1 promoter methylation status changes over time and correlates with changes in plasma adiponectin, VAT deposition and carotid atheroslcerosis in the M-CHAT subjects. These studies will provide insight into factors that contribute to VAT deposition and CVD risk in ethnic groups, and inform possible methods for identifying those at risk.
Programme
Operating Grant: Prevention of Cardiovascular and Respiratory Diseases
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
184883
Name
Devlin Angela M
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Operating Grant: Prevention of Cardiovascular and Respiratory Diseases
Projecttitle
Ethnic-Specific Variations in Adiponectin, Adiposity, & Risk for CVD
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$275,531
Cihrequipment2
$2,000
Programname2
Operating Grant: Prevention of Cardiovascular and Respiratory Diseases
Keyworddelim
Adiponectin; Adiposity; Cardiovascular Disease; Epigenomics; Ethnicity
Abstract
Twenty-three percent of adult Canadians are obese (BMI¡Ý30). Increased visceral adipose tissue (VAT), a component of obesity, is an independent risk factor for cardiovascular disease (CVD) but the molecular mechanisms underlying VAT deposition and how it leads to CVD are not known. The Multicultural Community Health Assessment Trial (M-CHAT) is a research program (Dr S Lear, Co-applicant) to explore obesity and CVD risk in Aboriginal, Chinese, European, and South Asian adults. Recent findings indicate that ethnicity predicts body fat distribution, independent of socioeconomic status and lifestyle. The objective of this proposal is to test the HYPOTHESIS that GENETIC AND/OR EPIGENETIC VARIATIONS in ADIPONECTIN (ADIPOQ gene) and ADIPONECTIN RECEPTOR (ADIPOR1 gene) EXPRESSION CONTRIBUTE to ETHNIC-SPECFIC DIFFERENCES in VAT and CVD RISK. We have chosen to focus on adiponectin because of the potential role for adiponectin in CVD and the inverse association of circulating adiponectin with VAT. These SPECIFIC AIMS will be addressed : 1. To determine the contribution of variants in ADIPOQ (A-11426G, G-11388A, C-11377G, and T45G), and ADIPOR1 (C-8503T, G-7308A, G-7302A, and G-6871A), and ADIPOQ and ADIPOR1 promoter methylation status to differences in plasma adiponectin, VAT deposition and carotid atherosclerosis in the M-CHAT subjects at baseline. 2.To determine the relationship of ADIPOQ and ADIPOR1 promoter methylation status and mRNA expression to differences in plasma adiponectin, VAT deposition and carotid atherosclerosis in a follow-up of M-CHAT subjects (3-4 yrs post baseline). 3. To determine if ADIPOQ and ADIPOR1 promoter methylation status changes over time and correlates with changes in plasma adiponectin, VAT deposition and carotid atheroslcerosis in the M-CHAT subjects. These studies will provide insight into factors that contribute to VAT deposition and CVD risk in ethnic groups, and inform possible methods for identifying those at risk.
Competitiondate
200904
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Devlin, Angela M
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $275,531~ $2,000~